The growing prevalence of thyroid disorders is turning heads among manufacturers in the disorders treatment and dietary supplements markets. It is now estimated that 20 million Americans have some form of thyroid disease, according to the American Thyroid Association.
While the space has traditionally relied on pharmaceuticals to treat these issues as they progress, exciting new evidence suggests that nutritional therapies, especially the trace mineral selenium, can provide preventive strategies by supporting thyroid health as well as promising protocols to improve thyroid function. Adequate selenium is essential to support the thyroid gland’s antioxidant function and production of metabolic hormones.
A detailed report by Transparency Market Research sheds more light on the potential of this market. The report states that thyroid gland disorders, such as hypothyroidism, hyperthyroidism and thyroid nodules affect between five percent and 10 percent of the population globally.
While the actual cause of thyroid disease is not known, the growing prevalence may be linked to increasing incidence of autoimmune diseases and lifestyle factors, like environmental toxins, and nutritional deficiencies. Beyond selenium deficiency, low iodine is also linked to thyroid problems and is now an increasing concern worldwide, even in industrialized nations like the United States.
Given these statistics, it is not surprising that the global thyroid gland disorders treatment market is on the rise. Sales of these treatments reached $1,954.7 million in 2016 and are predicted to hit $2,609.9 million by 2025, with a CAGR of 3.3 percent during that time period, according to the Transparency Market Research report. North America is the largest market for treatment of thyroid gland disorders, but the Asia Pacific market is likely to see the fastest growth in terms of drugs for these treatments.
Who’s at Risk for Thyroid Disorders?
- Women are especially at risk--they are five to eight times more likely than men to develop thyroid disorders.
- 60% of Americans with thyroid disease are unaware of their condition (which could put them at risk for other problems like heart disease or osteoporosis).
- Pregnant women are more likely to develop thyroid disorders. If undiagnosed it can lead to preterm delivery, miscarriage or developmental problems in the infant.
When it comes to nutritional therapies, selenium is particularly compelling. It is a required cofactor for three key enzymes involved in production of thyroid hormones, which assists in the production of a more metabolically active hormone.
As brands take a look at this opportunity, it is important to note that selenium form is critical in formulating effective products. Numerous studies in peer reviewed journals support evidence that organically bound selenium-enriched yeast is preferable because it improves the immunological mechanisms of action that support healthy thyroid function.
To ensure its thyroid formulas are viable, Ortho Molecular Products, a leading professional supplement line, utilized branded selenium ingredient SelenoExcell®, a clinically studied, bioavailable organic selenium that is the closest to forms found in nature.
To learn more about this exciting opportunity to develop relevant products for thyroid health and support, we have gathered a broad range of resources to cover all elements of your business needs, from the latest clinical research and market data to formulation insights and strategies.
Inside our Thyroid Market Spotlight:
- Formulator's Corner with Jim Roufs, MS, RD: Selenium and Thyroid
- Research Review, by Mark Whitacre, PhD: The latest research on micronutrients and thyroid health
- White Paper: Why Selenium-enriched yeast? Personalized medicine’s most useful mineral
- Product Highlights: Profiles of Ortho Molecular Products’ Thyrotain and Seleno-Iodide
- Good, Better, Best: Turnkey formulation options to meet your specific needs
- Cypress Ingredients to attend Supplyside East 2018